You are viewing: Brazil Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The Brazil Latent TB Testing Market was valued at $13.9 Million in 2024 and projected to reach to $21 Million by 2029, representing a compound annual growth rate of 8.7%. Brazil's latent TB testing market is positioned for sustained growth through 2029, driven by government TB elimination initiatives and increased diagnostic adoption across healthcare facilities.

Brazil Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Brazil Latent TB Testing Market Trends and Insights

  • This 8.7% compound annual growth rate significantly outpaces global trends, reflecting Brazil's heightened focus on tuberculosis control and diagnostic advancement.
  • Brazil's market growth is driven by increasing healthcare investments, rising TB prevalence awareness, and expanding access to advanced testing technologies across both public and private healthcare sectors. The latent TB testing landscape in Brazil is characterized by growing adoption of interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs) among healthcare providers and at-risk populations.
  • Brazil's strategic emphasis on TB elimination, coupled with improved reimbursement policies and diagnostic infrastructure development, positions the country as a key growth market within Latin America.
  • Between 2024 and 2029, Brazil is expected to see accelerated demand for latent TB diagnostics driven by occupational health programs, immunocompromised patient screening, and enhanced epidemiological surveillance initiatives..

Key Market Statistics

  • CAGR (2024-2029) 8.7% CAGR
  • Market Size, 2024 ~USD 13.9 Million
  • Forecast, 2029 ~USD 21 Million
  • Country Brazil

Brazil Latent TB Testing Market Overview

Strong Market Growth :

Brazil's latent TB testing market is expanding at 8.7% CAGR, significantly outpacing the global rate of 5.8%, driven by increased healthcare investments and TB control initiatives.

Market Valuation :

The market is valued at USD 13.9 million in 2024 and is projected to grow to USD 21.0 million by 2029, representing a 51% increase over the five-year forecast period.

Healthcare Infrastructure Investment :

Brazil's commitment to tuberculosis control programs and diagnostic advancement is fueling demand for latent TB testing solutions across public and private healthcare sectors.

Regional Leadership :

Brazil represents a key growth market in Latin America, with expanding diagnostic capabilities and rising awareness of latent TB screening importance among healthcare providers.

Brazil Latent TB Testing Market Dynamics

  • The country's expanding middle class and improved healthcare access are creating greater demand for preventive TB screening services.
  • Healthcare providers are increasingly recognizing the clinical and economic value of latent TB identification to prevent active disease progression. Investments in diagnostic infrastructure and training programs will further accelerate market expansion.
  • Public-private partnerships and international TB control collaborations are strengthening Brazil's testing capabilities.
  • The market's 8.7% CAGR reflects both rising disease awareness and the integration of advanced testing technologies into routine clinical practice across urban and emerging healthcare markets..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Brazil's latent TB testing market is valued at USD 13.9 million in 2024 and will grow to USD 21.0 million by 2029, representing an 8.7% CAGR.
    • Brazil's market growth rate significantly exceeds global averages, driven by increased TB control initiatives and diagnostic infrastructure expansion.
    • IGRA and TST adoption in Brazil is accelerating across occupational health, immunocompromised screening, and public health surveillance programs.
    • Brazil's improving reimbursement landscape and healthcare investments position it as Latin America's fastest-growing latent TB testing market.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    Brazil Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    BRAZIL: LATENT TB TESTING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES0.740.880.920.961.021.11.181.286.9
    DIAGNOSTIC LABORATORIES7.799.369.9810.7211.6312.713.9615.419.1
    HOSPITALS & CLINICS2.462.913.053.233.453.714.014.367.4
    OTHER END USERS0.30.350.360.370.390.410.440.475.2
    TOTAL11.2913.514.3115.2916.4917.9119.5921.528.5

    Target Audience

    • Diagnostic Device Manufacturers : Need Brazil-specific market data to assess commercial viability, plan product launches, and develop localized marketing strategies for latent TB testing technologies in this expanding market.
    • Healthcare System Administrators : Require market insights to justify TB screening program investments, benchmark diagnostic adoption rates, and align procurement strategies with Brazil's healthcare expansion initiatives.
    • Investment & Private Equity Firms : Seek detailed Brazil market analysis to evaluate investment opportunities in TB diagnostics companies, assess growth potential, and identify strategic acquisition targets in the region.
    • Pharmaceutical & Biotech Companies : Need country-level market intelligence to inform R&D priorities, licensing decisions, and commercial strategies for latent TB testing solutions tailored to Brazil's healthcare landscape.
    • Public Health & Government Agencies : Require market data to support TB elimination program planning, budget allocation, diagnostic infrastructure development, and evidence-based policy decisions for Brazil's healthcare system.

    Reasons to Buy this Report

    • Market-Specific Growth Data : Access precise valuation metrics for Brazil's latent TB testing market with detailed CAGR analysis, enabling accurate financial forecasting and investment planning specific to this high-growth region.
    • Competitive Landscape Intelligence : Understand Brazil's unique market dynamics, healthcare infrastructure, and competitive positioning to identify opportunities for market entry, partnerships, or expansion strategies.
    • Regulatory & Healthcare Insights : Gain country-specific knowledge of Brazil's TB control policies, diagnostic standards, and healthcare reimbursement frameworks essential for product development and commercialization strategies.
    • Strategic Investment Decisions : Leverage Brazil-focused market data to evaluate investment opportunities, assess market potential, and prioritize resource allocation in Latin America's largest healthcare market.
    • Demand Forecasting Accuracy : Utilize detailed Brazil market projections through 2029 to optimize supply chain planning, inventory management, and revenue forecasting for latent TB testing solutions.

    Frequently asked questions

    What is the current size of Brazil's latent TB testing market?

    Brazil's latent TB testing market was valued at USD 13.9 million in 2024 and is projected to reach USD 21.0 million by 2029.

    What is the expected growth rate for latent TB testing in Brazil?

    Brazil's latent TB testing market is expected to grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2029.

    What are the primary drivers of growth in Brazil's latent TB testing market?

    Key growth drivers in Brazil include increased TB control initiatives, expanding diagnostic infrastructure, improved reimbursement policies, occupational health programs, and enhanced epidemiological surveillance.

    Which testing methods are most commonly used in Brazil's latent TB market?

    Brazil's latent TB testing market primarily utilizes interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs), with growing adoption of advanced IGRA technologies.

    How does Brazil's latent TB testing market compare to global trends?

    Brazil's 8.7% CAGR significantly outpaces the global market CAGR of 5.8%, positioning Brazil as a high-growth market within the Latin American region.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status